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Correction: Vol. 11, No. 10
In “Methicillin-resistant Staphylococcus aureus Necro-
tizing Pneumonia,” by Monica Monaco et al., an error
occurred on page 1647, in the first full sentence of the third
column. The sentence should read “On day 3 of admission,
antimicrobial drug therapy was changed to linezolid (600
mg 2 times a day).”
The corrected text appears in the online article at
http://www.cdc.gov/ncidod/EID/vol11no10/05-0776.htm
We regret any confusion this error may have caused.
the global impact of HIV/AIDS. Each
chapter provides a well-referenced
overview of its topic with many refer-
ences as recent as 2003.
One of the real strengths of this
book is a chapter on quantitative sci-
ence that explores not only the history
of HIV clinical trials, but also the
design and importance of clinical tri-
als in general. This chapter should be
required reading for those considering
clinical research in HIV. The chapters
on Africa and Asia ably contrast the
differences in these areas of highest
prevalence. Another strength is the
discussion of HIV in correctional
facilities and the challenge of caring
for this population, including their
coexisting conditions and illicit drug
use. Lastly, the discussion of the eco-
nomics of AIDS is especially wel-
come in this era of efforts to increase
access to drugs worldwide. 
Overall, this book fills a valuable
niche. A relatively concise text, it
reviews many aspects of HIV with a
focus on how each topic has evolved
over the years. Afew tables are small,
but overall the diagrams and charts
are clear and legible. This book would
be of interest to infectious disease fel-
lows, HIV caregivers, and those
involved in public health and health
policy. I heartily recommend this
book and plan to keep it handy for
future reference.
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During the past 2 decades, the sci-
entific landscape of tickborne dis-
eases has changed remarkably. In part
because of advances in molecular
biology, more than 10 new rickettsial
diseases, several ehrlichial diseases,
and novel agents of Borrelia and
Babesia genera have been recognized.
This renaissance of interest in tick-
borne infections benefits from
advances in molecular phylogenetics
and diagnostics, immunology, and
informatics that provide tantalizing
insights into the complexities of vec-
torborne infection. Tick-Borne
Diseases of Humans is a well-refer-
enced textbook that encompasses
these new insights in vector biology
and reviews the emerging epidemiolo-
gy and clinical science of these dis-
eases as they occur across the globe.
The editors’goal of providing a “com-
prehensive” resource is admirably ful-
filled.
The book, consisting of 20 chap-
ters by 40 contributors, is divided into
3 sections. The first section includes
excellent reviews of tick biology and
systematics, tick-pathogen interac-
tions, host responses, and vector man-
agement. This section provides a
superb overview. While thorough and
up-to-date, occasional redundancy
occurs between chapters by different
authors that could have been stream-
lined with additional editing. A con-
cise and well-written chapter on the
clinical approach to diagnosis and
management of these diseases also
seems misplaced; it would fit in better
at the start of the next section.
Section 2 of the book includes
summaries of major and lesser known
tickborne infections. These chapters
each provide detailed information on
specific vectors and pathogens and on
the epidemiology and clinical charac-
teristics of the diseases they cause.
While the description of the molecu-
lar biology and vector ecology of
these infections is generally excellent,
the clinical discussions often lack the
nuance and detail of current infectious
diseases texts. Nevertheless, each
chapter provides current and well-
referenced information on disease
manifestations, diagnosis, and treat-
ment. Several chapters, i.e., those on
Correction: Vol 11, No. 8
In “Laboratory Exposures to Brucellae and Implications
for Bioterrorism” by Pablo Yagupsky and Ellen Jo Baron,
an error occurred in the dosage for rifampin prophylaxis. 
On page 1184, first column, first paragraph, the correct
dosage of rifampin is 600 mg once daily.
The corrected text appears in the online article at
http://www.cdc.gov/ncidod/EID/vol11no08/04-1197.htm 
We regret any confusion this error may have caused.